reSee.it - Tweets Saved By @GlynisFilyaw
@GlynisFilyaw - Glynis Filyaw
The War on Ivermectin (2 min 8 seconds) Please Share! The genie is out of the bottle. They don’t want you to have it, which is why you should have it and use it. This is Ivermectin🦄🐝🍀💫💜 https://t.co/F5XsPLoAQv
Video Transcript AI Summary
The video discusses the FDA's Emergency Use Authorization (EUA) process and the controversy surrounding the use of Ivermectin as a potential treatment for COVID-19. It highlights the financial interests of pharmaceutical companies and the geopolitical implications of widespread access to a cheap and widely available medicine like Ivermectin. The video also questions the safety claims made by Merck, the company that holds the expired patent for Ivermectin. It emphasizes the need for critical evaluation of articles and information that may be influenced by financial motives.
Full Transcript
Speaker 0: From the FDA, Emergency Use Authorization of Medical Products and Related Authorities. For the FDA to issue an emergency use authorization, adequate approved and available alternative to the candidate product for diagnosing, preventing, or treating the disease or If Ivermectin were an effective treatment, the vaccines never would have gotten emergency use authorization in the US.
Speaker 1: If a author Viable therapeutic strategy existed for outpatients, then the logic supporting universal vaccination with Largely experimental products is no longer supportable.
Speaker 2: The war on Ivermectin is waged by very powerful forces with a lot of money. I mean, Public health was built on a obsessive global vaccination policy, which Ivermectin would have threatened.
Speaker 0: We've got Pfizer's Q3 earnings. Revenue, they're projecting to be 98 to $102,000,000,000.
Speaker 3: Pfizer, BioNTech, and Moderna. Do you know how much profit they made from these shots? $1,000 every second from Wuhan virus vaccines. Author
Speaker 2: You're talking about 100 of 1,000,000,000 of dollars in geopolitical implications that would affected if the people had access to a safe and widely available medicine.
Speaker 4: This is an incredibly cheap Drug. It's off license. It's generic. It can be manufactured in huge amounts in India. Remarkably low cost.
Speaker 0: Authorization, Merck's patent on Ivermectin expired in 1996. In 2021, Merck released a statement claiming that Ivermectin was not an effective treatment against COVID nineteen and bizarrely claimed, quote, a concerning lack of safety data in the majority of studies. It was plenty safe for Merck to distribute widely when it was still under patent, but now they're claiming the I mean, the safety record is insufficient.
Speaker 1: Folks need to understand that just because there is an article out there That asserts that something is false, recognize that those are paid.